These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 1348920

  • 1. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
    Volm M, Efferth T, Mattern J.
    Anticancer Res; 1992; 12(1):11-20. PubMed ID: 1348920
    [Abstract] [Full Text] [Related]

  • 2. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M, Mattern J.
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [Abstract] [Full Text] [Related]

  • 3. P-glycoprotein associated expression of c-fos and c-jun products in human lung carcinomas.
    Volm M.
    Anticancer Res; 1993; 13(2):375-8. PubMed ID: 8100127
    [Abstract] [Full Text] [Related]

  • 4. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 5. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
    Kohler M, Janz I, Wintzer HO, Wagner E, Bauknecht T.
    Anticancer Res; 1989 May; 9(6):1537-47. PubMed ID: 2697181
    [Abstract] [Full Text] [Related]

  • 6. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
    Giatromanolaki A, Koukourakis MI, Sivridis E, Fountzilas G.
    Anticancer Res; 2000 May; 20(2A):997-1004. PubMed ID: 10810387
    [Abstract] [Full Text] [Related]

  • 7. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K, Ishida H, Furukawa T, Koyanagi K, Miyamoto Y.
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A, Koukourakis MI, Kakolyris S, Turley H, O'Byrne K, Scott PA, Pezzella F, Georgoulias V, Harris AL, Gatter KC.
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [Abstract] [Full Text] [Related]

  • 9. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.
    Pavelic K, Antonic M, Pavelic L, Pavelic J, Pavelic Z, Spaventi S.
    Anticancer Res; 1992 Dec; 12(6B):2191-6. PubMed ID: 1363516
    [Abstract] [Full Text] [Related]

  • 10. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM, Finkelstein SD, Langer JC, Swalsky PA, Fishback N, Bakker A, Guinee DG, Koss M, Travis WD.
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [Abstract] [Full Text] [Related]

  • 11. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
    Yamashita H, Murakami N, Asari T, Okuma K, Ohtomo K, Nakagawa K.
    Int J Radiat Oncol Biol Phys; 2009 Jul 15; 74(4):1165-72. PubMed ID: 19101092
    [Abstract] [Full Text] [Related]

  • 12. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H, Irie K, Itoh T, Furukawa T, Tokunaga O.
    Cancer; 1997 Sep 15; 80(6):1034-45. PubMed ID: 9305703
    [Abstract] [Full Text] [Related]

  • 13. [Positive expression of c-myc and p53 products in two cases of pulmonary sclerosing hemangioma].
    Chiba W, Sawai S, Yasuda Y, Wazawa H, Matsubara Y, Ikeda S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec 15; 33(12):1348-54. PubMed ID: 8821986
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis.
    Vora HH, Shah NG, Patel DD, Trivedi TI, Chikhlikar PR.
    J Surg Oncol; 2003 Jan 15; 82(1):34-50. PubMed ID: 12501167
    [Abstract] [Full Text] [Related]

  • 18. [DNA content analysis and detection of c-myc and p53 products using flow cytometry in resected lung cancer cases].
    Chiba W, Sawai S, Ikeda S, Morimoto K, Wazawa H, Hanawa T, Yamashita N, Matsui T, Hatakenaka R, Matsubara Y.
    Gan To Kagaku Ryoho; 1994 May 15; 21 Suppl 1():108-16. PubMed ID: 8203922
    [Abstract] [Full Text] [Related]

  • 19. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
    Gorgoulis VG, Zacharatos P, Mariatos G, Liloglou T, Kokotas S, Kastrinakis N, Kotsinas A, Athanasiou A, Foukas P, Zoumpourlis V, Kletsas D, Ikonomopoulos J, Asimacopoulos PJ, Kittas C, Field JK.
    Cancer Res; 2001 Jan 15; 61(2):538-49. PubMed ID: 11212247
    [Abstract] [Full Text] [Related]

  • 20. Reliability of platelet-derived endothelial cell growth factor as a prognostic factor for oral and oropharyngeal carcinomas.
    Tsuzuki H, Sunaga H, Ito T, Narita N, Sugimoto C, Fujieda S.
    Arch Otolaryngol Head Neck Surg; 2005 Dec 15; 131(12):1071-8. PubMed ID: 16365220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.